Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA166973
Max Phase: Preclinical
Molecular Formula: C21H45NO2
Molecular Weight: 343.60
Molecule Type: Small molecule
Associated Items:
ID: ALA166973
Max Phase: Preclinical
Molecular Formula: C21H45NO2
Molecular Weight: 343.60
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCCC[C@H](N)[C@H](O)CO
Standard InChI: InChI=1S/C21H45NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20(22)21(24)19-23/h20-21,23-24H,2-19,22H2,1H3/t20-,21+/m0/s1
Standard InChI Key: KTJHXKWNUDUKPY-LEWJYISDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 343.60 | Molecular Weight (Monoisotopic): 343.3450 | AlogP: 5.32 | #Rotatable Bonds: 19 |
Polar Surface Area: 66.48 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.78 | CX Basic pKa: 9.51 | CX LogP: 6.11 | CX LogD: 4.04 |
Aromatic Rings: 0 | Heavy Atoms: 24 | QED Weighted: 0.28 | Np Likeness Score: 0.73 |
1. Padrón JM, Martin VS, Hadjipavlou-Litina D, Noula C, Constantinou-Kokotou V, Peters GJ, Kokotos G.. (1999) Synthesis, in vitro cytotoxicity and in vivo anti-inflammatory activity of long chain 3-amino-1,2-diols., 9 (6): [PMID:10206543] [10.1016/s0960-894x(99)00084-0] |
Source(1):